.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Merck
McKinsey
Healthtrust
Fuji
QuintilesIMS
Cantor Fitzgerald
Mallinckrodt
McKesson

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040362

« Back to Dashboard
NDA 040362 describes PREDNISONE, which is a drug marketed by Halsey, West-ward Pharms Int, Marshall Pharma, Mutual Pharm, Vangard, Inwood Labs, Vitarine, Phoenix Labs Ny, Contract Pharmacal, Roxane, Elkins Sinn, Jubilant Cadista, Aurolife Pharma Llc, Watson Labs, Whiteworth Town Plsn, Lannett, Nylos, Heather, Wockhardt, Mylan Pharms Inc, Rexall, Ivax Sub Teva Pharms, Kv Pharm, Sandoz, Valeant Pharm Intl, Hikma Pharms, Everylife, Sun Pharm Inds, Panray, Pvt Form, Purepac Pharm, Vintage Pharms, Chartwell Rx, Sperti, Pharmavite, Ferrante, Superpharm, Actavis Labs Fl Inc, Lederle, Upsher Smith, Scherer Labs, Bundy, Impax Labs, UDL, Am Therap, Duramed Pharms Barr, Amneal Pharms Ny, and Teva, and is included in one hundred and seven NDAs. It is available from fifty-five suppliers. Additional details are available on the PREDNISONE profile page.

The generic ingredient in PREDNISONE is prednisone. There are sixteen drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the prednisone profile page.

Summary for 040362

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 040362

Suppliers and Packaging for NDA: 040362

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PREDNISONE
prednisone
TABLET;ORAL 040362 ANDA Blenheim Pharmacal, Inc. 10544-913 10544-913-30 30 TABLET in 1 BOTTLE (10544-913-30)
PREDNISONE
prednisone
TABLET;ORAL 040362 ANDA Blenheim Pharmacal, Inc. 10544-914 10544-914-20 20 TABLET in 1 BOTTLE (10544-914-20)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Aug 29, 2001TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Aug 29, 2001TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Jun 29, 2005TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Baxter
Cipla
Mallinckrodt
US Army
Chubb
Farmers Insurance
Merck
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot